Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
NATCOPHARM
NATCOPHARM
791.85+6.7 (+0.85%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

98.4 / 100

Value Score

82.7 / 100

Price Momentum Score

41.8 / 100

QVM Score

93.9 / 100

Key Metrics

Market Cap
15533.60
P/E (TTM)
13.57
P/B
1.68
P/S (TTM)
4.46
EV/EBITDA
12.72
CAPE (5Y)
12.56
ROE (TTM)
16.86
ROCE (TTM)
13.80
ROA (TTM)
14.40
Avg 3Y ROE
23.59
Earnings 3Y CAGR
12.49
Sales 3Y CAGR
5.55
Sales 5Y CAGR
12.91
Debt/Equity
0.08
Consensus TP
991.86
Strong Buy %
25.00
Promoter Holding
49.39
Pledged %
0.00

Share Price

Track Natco Pharma Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 0.87 %
Low
773.6
High
809.8
1 Month returns: -4.69 %
Low
773.6
High
850.9
1 Year returns: -4.24 %
Low
773.6
High
1,216.9
3 Year CAGR: -0.69 %
Low
654.7
High
1,625.8
5 Year CAGR: -1.11 %
Low
497.9
High
1,625.8
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Natco Pharma Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Natco Pharma Ltd. Shareholding Pattern

Quarterly breakdown of Natco Pharma Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Natco Pharma Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Natco Pharma Ltd.?
The current share price of Natco Pharma Ltd. is ₹ 791.85 as of 23 Oct 2026.
What is the market capitalisation of Natco Pharma Ltd.?
The market capitalisation of Natco Pharma Ltd. stands at ₹ 15,533.60 Cr.
What is the PE ratio of Natco Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Natco Pharma Ltd. is 13.57 as of the latest trailing twelve months data.
What is the ROE and ROCE of Natco Pharma Ltd.?
Natco Pharma Ltd. has a Return on Equity (ROE) of 16.86% and a Return on Capital Employed (ROCE) of 13.80% as per the latest financial reports.
What is the 52-week high and low of Natco Pharma Ltd.?
The 52-week high of Natco Pharma Ltd. is - and the 52-week low is -.
What is the dividend yield of Natco Pharma Ltd.?
The dividend yield of Natco Pharma Ltd. is 0.63% based on the current market price.
What is the FII and DII holding in Natco Pharma Ltd.?
Foreign Institutional Investors (FII) hold 15.99%, Domestic Institutional Investors (DII) hold 6.05% and retail/public investors hold 26.87% of Natco Pharma Ltd. shares.
What sector does Natco Pharma Ltd. belong to?
Natco Pharma Ltd. operates in the Healthcare sector. 37.5% of analysts have a Buy or Strong Buy rating on Natco Pharma Ltd. with a consensus target price of ₹ 991.86, implying 25.26% upside from current levels.
What is the beta of Natco Pharma Ltd.?
The beta of Natco Pharma Ltd. is 0.90, indicating its price volatility relative to the broader market. Over the past 1 year, Natco Pharma Ltd. has delivered an absolute return of -2.69%.
What is the RSI of Natco Pharma Ltd.?
The 14-day Relative Strength Index (RSI) of Natco Pharma Ltd. is 41.93, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.